MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cbi.2025.111750

Медицинская библиотека · Chemico-biological interactions · 2025

Erianin reverses 5-FU resistance by targeting CALM1/CAMKK2 and activating autophagy in colorectal cancer.

Zhou Fangyuan, Shang Luorui, Li Jinxiao, Zhang Mengqi, Wang Shuhan, Cai Yuju, Lin Qifeng, Gao Haiyang, Yang Shenglan

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Chemoresistance represents a significant factor contributing to the failure of clinical treatments in colorectal cancer (CRC), with resistance to 5-fluorouracil (5-FU) being notably prevalent. Erianin has demonstrated potential in reversing tumor resistance; however, its specific effects and underlying mechanisms in the context of 5-FU-resistant CRC require comprehensive validation.

METHODS

The half-maximal inhibitory concentration (IC50) of Erianin and 5-FU was determined using the CCK8 assay. CRC cells resistant to 5-FU were induced by progressively increasing concentrations of 5-FU. Cellular proliferation, migration, and invasion were evaluated via 5-ethynyl-2'-deoxyuridine (EdU) assays, wound-healing assays, and Transwell Matrigel invasion assays. The expression levels of protein and mRNA expression levels for various molecules were quantified using Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR). Immunofluorescence assays were employed to assess the expression of autophagy-related markers. The in vivo therapeutic efficacy of Erianin was assessed using a xenograft tumor model.

RESULTS

Erianin effectively reinstated the sensitivity of 5-FU-resistant CRC cells to 5-FU, significantly reducing tumor cell proliferation, migration, and invasion, as well as inhibiting xenograft tumor growth. Mechanistic investigations demonstrated that Erianin targets and binds to the calmodulin 1 (CALM1) protein, enhancing its stability and subsequently increasing the phosphorylation levels of CAMKK2. This interaction facilitates autophagy in 5-FU-resistant CRC cells, ultimately leading to tumor cell death.

CONCLUSION

Erianin sensitized the resistant CRC cells to 5-FU by activating the CALM1/CAMKK2 signaling pathway, thereby inducing autophagy. The combination of 5-FU and Erianin presents a promising therapeutic approach to enhance survival outcomes in patients with refractory CRC.

Для цитирования: Zhou Fangyuan, Shang Luorui, Li Jinxiao, Zhang Mengqi, Wang Shuhan, Cai Yuju, Lin Qifeng, Gao Haiyang, Yang Shenglan. Erianin reverses 5-FU resistance by targeting CALM1/CAMKK2 and activating autophagy in colorectal cancer.. Chemico-biological interactions. 2025. DOI: 10.1016/j.cbi.2025.111750.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.